Home › Funds › Incision Capital Management LP › CROX
Incision Capital Management LP position in CROX
CROCS INC · Consumer Discretionary
Incision Capital Management LP reported holding 60,000 shares of CROX (CROCS INC) in its Q3 2026 13F filing — a position valued at US$7.0M, representing 7.12% of its reported portfolio and ranking #6 among its reported holdings. Incision Capital Management LP has disclosed CROX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Incision Capital Management LP's CROX position evolved
Incision Capital Management LP first disclosed a stake in CROX in Q4 2025 at 325,000 shares (US$27.8M). The position peaked in Q1 2026 at 350,000 shares, worth US$29.1M. Across 4 filings, Incision Capital Management LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 60,000 shares valued at US$7.0M — a reduction of -150,000 shares quarter over quarter.. Notable position changes include a 40% trim in Q2 2026 (shares fell 2% over the following quarter), a 71% trim in Q3 2026 (shares rose 40% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 325.00K | $27.79M | New |
| Q1 2026 | 350.00K | $29.06M | Add |
| Q2 2026 | 210.00K | $25.33M | Reduce |
| Q3 2026 | 60.00K | $7.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CROX and 13F data
CROX (CROCS INC) is a Consumer Discretionary company. 28 other funds we track also report a position in CROX — the largest reported positions include Himalaya Capital (US$107.0M), No Street GP LP (US$98.9M), Patient Capital Management, LLC (US$85.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CROX
- Himalaya Capital 887.09K sh · $107.02M · Q2 2026
- No Street GP LP 820.00K sh · $98.92M · Q2 2026
- Patient Capital Management, LLC 730.95K sh · $85.75M · Q3 2026
- Smead Capital Management, Inc. 709.82K sh · $83.27M · Q3 2026
- DME Capital Management, LP 669.14K sh · $80.73M · Q2 2026
- WIT Partners Advisory Pte. Ltd. 632.81K sh · $74.24M · Q3 2026
- Evercore Wealth Management, LLC 594.86K sh · $71.76M · Q2 2026
- Punch Card Management L.P. 577.17K sh · $69.63M · Q2 2026
More on Incision Capital Management LP
FAQ
How long has Incision Capital Management LP held CROX?
Incision Capital Management LP has disclosed CROX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Incision Capital Management LP's current position in CROX?
As of Q3 2026, Incision Capital Management LP holds 60.00K shares of CROX (CROCS INC), valued at $7.04M, representing 7.12% of its reported portfolio and ranking #6.
Has Incision Capital Management LP been buying or selling CROX?
In the latest 13F filing (Q3 2026), Incision Capital Management LP reduced its position in CROX. The position peaked in Q1 2026 at 350.00K shares.
Which other funds hold CROX?
Other major institutional holders of CROX include Himalaya Capital, No Street GP LP, Patient Capital Management, LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.